Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are COVID-19, Cerebral Palsy, Acute Eosinophilic Pneumonia, and Hypereosinophilic Syndrome.

Dr. Daniel Ford is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in psychiatry and behavioral sciences and, at the Johns Hopkins Bloomberg School of Public Health, in health policy and management and in epidemiology. Dr. Ford serves as the director of the Institute for Clinical and Translational Research and the senior associate dean for clinical and translational research at the Johns Hopkins School of Medicine. Widely regarded as a pioneer in research associated with the interrelationships between mental disorders and chronic medical conditions, Dr. Ford gained international acclaim for clinical studies documenting depression as an independent risk factor for coronary heart disease and for research describing the long-term health risks related to sleep disturbances. He was chosen by the Robert Wood Johnson Foundation to direct the evaluation of its $12 million Depression in Primary Care Initiative. He also has been the principal researcher on a large training grant to develop researchers in general internal medicine. A leader in using the Internet for clinical research, Dr. Ford worked closely with Johns Hopkins personnel who developed e-IRB, an electronic process for submitting research proposals to the school of medicine’s Institutional Review Board, which oversees requests to launch clinical studies. His research interests include ways to improve the treatment of chronic diseases through information technology. He also advocates treating human research subjects as partners, ensuring that they receive sufficient thanks for their commitment and willingness to contribute to scientific progress. Dr. Ford received his M.D. from the State University of New York at Buffalo in 1982. He arrived at Hopkins that year as a medical resident and, except for a brief period as a National Institutes of Health fellow, has been on the Johns Hopkins faculty ever since. He received his master’s degree in public health from the Bloomberg School in 1986. He has published more than 120 research papers and book chapters, and was associate editor of the Journal of General Internal Medicine and a member of the editorial board of General Hospital Psychiatry. Dr. Ford is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Muscle Invasive Bladder Cancer, Agranulocytosis, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Hilary Whitlatch is an Endocrinologist in Baltimore, Maryland. Dr. Whitlatch is rated as a Distinguished provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Rabson-Mendenhall Syndrome, Hyperparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Rachel M. Kruzan is an instructor of medicine at the Johns Hopkins University School of Medicine. Her area of clinical expertise is internal medicine. Dr. Kruzan earned her M.D. from Rush Medical College. She completed her residency at Johns Hopkins Bayview Medical Center. She has been recognized by the Johns Hopkins Institutions Diversity Leadership Council with a Diversity Recognition Award. Dr. Kruzan is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Diabetic Neuropathy, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Familial Hypertension.

Marjorie Pennant is an Endocrinologist in Baltimore, Maryland. Dr. Pennant is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Storm, and Hyperthyroidism.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Khalid El-Bedawi is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. El-Bedawi is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Ballinger-Wallace Syndrome, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. El-Bedawi is currently accepting new patients.

Barbara Kalazny is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Kalazny is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Parkinson's Disease, Rabson-Mendenhall Syndrome, Glucocorticoid-Remediable Aldosteronism, and Hypertension. Dr. Kalazny is currently accepting new patients.

Anil Uberoi is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Uberoi is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Ballinger-Wallace Syndrome, Rabson-Mendenhall Syndrome, Asthma, and Familial Hypertension. Dr. Uberoi is currently accepting new patients.

Malek Cheikh is an Endocrinologist in Baltimore, Maryland. Dr. Cheikh is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Carl Sperling is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Sperling is rated as an Advanced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Rabson-Mendenhall Syndrome, End-Stage Renal Disease (ESRD), Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Rachael Oxman is an Endocrinologist in Baltimore, Maryland. Dr. Oxman is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Rabson-Mendenhall Syndrome.

Rana Malek is an Endocrinologist in Baltimore, Maryland. Dr. Malek is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Addison's Disease, Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroidectomy.

Elizabeth Lamos is an Endocrinologist in Baltimore, Maryland. Dr. Lamos is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hyperthyroidism, and Thyroid Storm.

Shoshana Weiner is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Weiner is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Sickle Cell Disease, Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, and Hypertensive Heart Disease.

Kristi Silver is an Endocrinologist in Baltimore, Maryland. Dr. Silver is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Thyroid Storm, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Emily Japp is an Endocrinologist in Baltimore, Maryland. Dr. Japp is rated as an Experienced provider by MediFind in the treatment of Rabson-Mendenhall Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Thyroid Nodule, Hypercalcemia, and Milk-Alkali Syndrome.